Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Position Decreased by Russell Investments Group Ltd.

Russell Investments Group Ltd. reduced its holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 39.4% during the fourth quarter, Holdings Channel reports. The firm owned 32,306 shares of the biopharmaceutical company’s stock after selling 21,017 shares during the period. Russell Investments Group Ltd.’s holdings in Intra-Cellular Therapies were worth $2,698,000 at the end […]